Skip to main content
. Author manuscript; available in PMC: 2015 Jun 24.
Published in final edited form as: J Urol. 2012 Oct 8;189(2):762–768. doi: 10.1016/j.juro.2012.08.198

Figure 1.

Figure 1

NOS signaling changes in SCD-associated priapism. A.) PDE5 expression (100 kDa) significantly decreased in the SCD group compared to both the Control and non-SCD groups. B.) eNOS expression (140 kDa) significantly decreased in both SCD and non-SCD groups compared to Control. C.) nNOS expression (160 kDa) was similar among all groups. * p<0.05 vs. Control, † p<0.05 vs. non-SCD. Top panels: representative immunoblots; bottom panel: densitometry data; bars represent mean ± SEM of 5–6 patients per group. All protein expressions were normalized to β-actin and expressed as a ratio of Control values. (SCD = patients with sickle cell disease, non-SCD = patients with priapism of other etiologies).